semaglutide supply issues Dr Reddy's Delays After Quality Issue The GLP-1 drug shortage is
Description
The authors suggest further randomized controlled trials to explore the therapeutic potential of GLP-1 agonists and GIP/GLP-1 combination drugs to treat alcohol use disorder, which affects 5.9 percent of individuals in the United States ages 12 and older
Grucza RA, Krueger RF, Racette SB, Norberg KE, Hipp PR, Bierut LJ
Retrieved on March 27th, 2013 from More4Kids
Additionally, optimizing access and equity in pharmacotherapy, as well as integrating these treatments into comprehensive care models, are critical areas for future investigation
